Satyavrat Shukla

Satyavrat Shukla

No más puestos en curso

Fortuna: 99 149 $ al 31/08/2026

54 años
Health Technology
Consumer Services
Commercial Services

Perfil

Satyavrat Shukla worked at Cornerstone Research, Inc. as Principal from 2003 to 2012.
Then worked at Vertex Pharmaceuticals, Inc. as Vice President & Global Head-Corporate Finance from 2012 to 2019.
Worked at Alaunos Therapeutics, Inc. as Chief Financial Officer & Executive Vice President from 2019 to 2020.
Worked at Spero Therapeutics, Inc. as Director in 2025.
Education includes an undergraduate degree from Harvard University in 1993 and an MBA from Yale University in 1999.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/04/2026 81.270 ( 0,14 % ) 99 149 $ 31/08/2026

Antiguos cargos conocidos de Satyavrat Shukla.

EmpresasCargoFin
SPERO THERAPEUTICS, INC. Director Ejecutivo 10/01/2025
ALAUNOS THERAPEUTICS, INC. Director Financiero/CFO 31/12/2020
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/07/2019
Corporate Officer/Principal 01/01/2012
Ver el detalle de la experiencia de Satyavrat Shukla.

Formación de Satyavrat Shukla.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

97

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Satyavrat Shukla